38533-61-8

Basic information

• Product Name: 2-Chloro-6-methoxy-3-nitropyridine
• Synonyms: 2-Choro-3-nitro-6-methoxypyridine;2-CHLORO-3-NITRO-METHOXYPYRIDINE;Pyridine, 2-chloro-6-methoxy-3-nitro-;2-Chloro-6-methoxy-3-nitropyridine ,98%;2-chloro-3-aMino-6-Methoxypyridine;2-CHLORO-3-NITRO-6-METHOXYPYRIDINE;2-CHLORO-6-METHOXY-3-NITROPYRIDINE;2-CHLORO-6-METHOXY-(3 OR 5)-NITROPYRIDINE
• CAS NO: 38533-61-8
• Molecular Formula: C₆H₅ClN₂O₃
• Molecular Weight: 188.57
• EINECS: 253-989-8
• Product Categories: compounds of pyridine;blocks;Pyridines;Pyridine;Pyridine series;Halides;Chloropyridines;Halopyridines;C6Heterocyclic Building Blocks;Halogenated Heterocycles;Heterocyclic Building Blocks;Heterocycle-Pyridine series;alkyl chloride|nitro-compound
• Mol File: 38533-61-8.mol
• Article Data: 7

Chemical Properties

• Melting Point: 78-80 °C(lit.)
• Boiling Point: 298.5 °C at 760 mmHg
• Flash Point: 134.4 °C
• Appearance: Off-white to yellow/Powder
• Density: 1.445 g/cm³
• Vapor Pressure: 0.00224mmHg at 25°C
• Refractive Index: 1.564
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• PKA: -2.34±0.10(Predicted)
• Water Solubility: Slightly soluble in water.
• CAS DataBase Reference: 2-Chloro-6-methoxy-3-nitropyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Chloro-6-methoxy-3-nitropyridine(38533-61-8)
• EPA Substance Registry System: 2-Chloro-6-methoxy-3-nitropyridine(38533-61-8)

Safety Data

• Hazard Codes: Xi,Xn
• Statements: 36/37/38-44-20/21/22
• Safety Statements: 26-37/39-36/37/39
• WGK Germany: 3
• HazardClass: 6.1
• Hazardous Substances Data: 38533-61-8(Hazardous Substances Data)

Usage

Chemical Properties

Light yellow Cryst

Uses

6-methoxy-3-nitropyridine-2-carbonitrile was synthesised from 2-Chloro-6-methoxy-3-nitropyridine. Reatant in the suzuki and negishi couplings reaction. Also as fine chemical intermediate.

InChI:InChI=1/C6H5ClN2O3/c1-12-5-3-2-4(9(10)11)6(7)8-5/h2-3H,1H3

Upstream product

• 67-56-1 methanol 
• 16013-85-7 2,6-dicholoro-3-nitropyridine 
• 124-41-4 sodium methylate 
• 17228-64-7 6-chloro-2-methoxypyridine 

Downstream Products

• 73896-36-3 6-methoxy-3-nitropyridin-2-amine 
• 727993-33-1 6-methoxy-3-nitro-2-(trifluoromethyl)pyridine 
• 866396-80-7 [4-(6-methoxy-3-nitro-pyridin-2-ylamino)-cyclohexyl]-carbamic acid tert-butyl ester 
• 94166-59-3 2-(2-hydroxyethylamino)-6-methoxy-3-nitropyridine 
• 96902-13-5 N-(6-methoxy-3-nitro-pyridin-2-yl)-N',N'-dimethylpropane-1,3-diamine 
• 1258786-29-6 6-methoxy-3-nitro-2-(toluene-4-sulfonyl)-pyridine 
• 1192300-66-5 Methyl 5-chloro-2-(2-fluorophenyl)-2-(6-methoxy-3-nitropyridin-2-yl) pentanoate 
• 1192300-70-1 Methyl 6-chloro-2-(2-fluorophenyl)-2-(6-methoxy-3-nitropyridin-2-yl)hexanoate 
• 1192300-62-1 Methyl (2-fluorophenyl)(6-methoxy-3-nitropyridin-2-yl)acetate 
• 1224884-54-1 2-methoxy-7-methyl-9-o-tolylimidazo[5,1-c]pyrido[2,3-e][1,2,4]triazine 
• 1224883-93-5 9-(4-fluoro-2-methylphenyl)-2-methoxy-7-methylimidazo[5,1-c]pyrido[2,3-e][1,2,4]triazine 
• 1224883-30-0 1-(2-chlorophenyl)-8-methoxy-3-methyl-imidazo[5,1-c]-pyrido[2,3-e]-1,2,4-triazine 
• 1224884-41-6 9-(2,4-dichlorophenyl)-2-methoxy-7-methylimidazo[5,1-c]pyrido[2,3-e][1,2,4]triazine 
• 1224884-21-2 9-(2-chloro-4-fluorophenyl)-2-methoxy-7-methylimidazo[5,1-c]pyrido[2,3-e][1,2,4]triazine 

Relevant articles and documents

SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE

The present invention provides compounds of Formula (I) or a subgeneric structure or species thereof, or a pharmaceutically acceptable salt, ester, solvate, and/or prodrug thereof, and methods and compositions for treating or ameliorating abnormal cell proliferative disorders, such as cancer, wherein A, R2, R3, R10, E1, E2, E3, Y, and Z are as defined herein.

Ortho-selectivity in the nucleophilic aromatic substitution (S NAr) reactions of 3-substituted, 2,6-dichloropyridines with alkali metal alkoxides

3-Substituted, 2,6-dichloropyridines have featured in the syntheses of small molecule inhibitors of a wide variety of biological targets. Hence, the regioselective displacement of the chlorines is of significant interest. Through conducting an extensive solvent study, we have found that non-polar, aprotic solvents of low hydrogen bond basicities favour substitution of the chlorine ortho to the 3-substituent by alkali metal alkoxides. We present convincing evidence that coordination of the alkali metal counter-ion to the 3-substituent (nitro, ester, amide) is the origin of the ortho-selectivity to give a cyclic, six-membered transition state. Excellent ortho-selectivities (≥98:2) for secondary and tertiary alkoxides were realized with the sodium counter-ion, whereas the more reactive primary alkoxides required the harder, more Lewis acidic lithium counter-ion.

Cell adhesion inhibitors

The present invention relates to novel compounds that are useful for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention also relates to pharmaceutical formulations comprising these compounds and methods of using them for inhibition and prevention of cell adhesion and cell adhesion-mediated pathologies. The compounds and pharmaceutical compositions of this invention can be used as therapeutic or prophylactic agents. They are particularly well-suited for treatment of many inflammatory and autoimmune diseases.